High expression of membranous CD138 has been shown to be associated with a favorable outcome in various malignancies such as HNSCC, mesothelioma, gastric, and hepatocellular cancer, and with an unfavorable outcome in other malignancies such as pancreatic, ovarian, and thyroid cancer [19,28]. The gene discussed is SDC1; the disease is hepatocellular carcinoma.